Is It Time To Reassess Amgen (AMGN) After Strong Recent Share Price Gains

Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge.

Amgen’s share price can tell you a lot about what the market thinks it is worth, but the real question is whether that price still lines up with the underlying value of the business.

In the last week Amgen returned 6.8%, over the past month 10.9%, year to date 11.8%, over the last year 27.0%, over three years 67.9% and over five years 81.0%. Taken together, these figures give investors a useful snapshot of how sentiment around the stock has shifted over different time frames.

Recent news coverage around Amgen has focused on its position in the large cap biotech space and how investors are weighing its product…

Source link